![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACET market cap is 125.7M. The company's latest EPS is USD -1.7361 and P/E is -1.31.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -31.57M | -33.32M | -34.89M | -52.26M | -31.57M |
Net Income | -29.88M | -30.88M | -32.4M | -49.89M | -29.49M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 17.9M | 9.73M | 24.99M | 0 |
Operating Income | -85.46M | -39.19M | -62.04M | -72.55M | -152.04M |
Net Income | -82.74M | -36.68M | -62M | -69.79M | -142.66M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 330.69M | 304.97M | 277.63M | 233.26M | 207.3M |
Total Liabilities | 38.35M | 38.76M | 38.57M | 38.58M | 37.12M |
Total Equity | 292.34M | 266.22M | 239.06M | 194.68M | 170.18M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 93.91M | 153.84M | 338.94M | 330.69M | 207.3M |
Total Liabilities | 12.21M | 44.01M | 35.81M | 38.35M | 37.12M |
Total Equity | 81.7M | 109.83M | 303.13M | 292.34M | 170.18M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -44.77M | -24.09M | -48.99M | -70.23M | -93.72M |
Investing | -16.78M | -1.92M | -3.42M | -4.33M | -4.46M |
Financing | 41.51M | -7k | 219k | 160k | 236k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -73.68M | -43.85M | -51.05M | -44.77M | -93.72M |
Investing | 44.13M | 115.22M | -2.8M | -16.78M | -4.46M |
Financing | 56.45M | 303k | 242.69M | 41.51M | 236k |
Market Cap | 125.7M |
Price to Earnings Ratio | -1.31 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.17 |
Price to Book Ratio | 1.1 |
Dividend Yield | - |
Shares Outstanding | 82.17M |
Average Volume (1 week) | 514.5k |
Average Volume (1 Month) | 630.96k |
52 Week Change | -67.17% |
52 Week High | 4.81 |
52 Week Low | 1.10 |
Spread (Intraday) | 1.94 (56.89%) |
Company Name | Adicet Bio Inc |
Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
Website | https://www.adicetbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions